# A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

> **NCT04369391** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** SEP363856 150 mg
- **DRUG:** Placebo
- **DRUG:** moxifloxacin 400 mg

## Key facts

- **NCT ID:** NCT04369391
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2020-11-10
- **Final completion:** 2020-11-10
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369391, "A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04369391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*